Kunjithapatham, R., & Ganapathy-Kanniappan, S. (2018). GAPDH with NAD+-binding site mutation competitively inhibits the wild-type and affects glucose metabolism in cancer. Biochimica et biophysica acta. General subjects, 1862(12), 2555-2563. https://doi.org/10.1016/j.bbagen.2018.08.001
Chicago Style (17th ed.) CitationKunjithapatham, Rani, and Shanmugasundaram Ganapathy-Kanniappan. "GAPDH with NAD+-binding Site Mutation Competitively Inhibits the Wild-type and Affects Glucose Metabolism in Cancer." Biochimica Et Biophysica Acta. General Subjects 1862, no. 12 (2018): 2555-2563. https://doi.org/10.1016/j.bbagen.2018.08.001.
MLA (9th ed.) CitationKunjithapatham, Rani, and Shanmugasundaram Ganapathy-Kanniappan. "GAPDH with NAD+-binding Site Mutation Competitively Inhibits the Wild-type and Affects Glucose Metabolism in Cancer." Biochimica Et Biophysica Acta. General Subjects, vol. 1862, no. 12, 2018, pp. 2555-2563, https://doi.org/10.1016/j.bbagen.2018.08.001.